-
Symbol
-
KYTX on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.00001 per share
-
Latest Disclosed Shares Owned
-
4,657,257 shares
-
Security Ownership %
-
7.8%
Dr. Beth C. Seidenberg ("Seidenberg") ownership in Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX)
06 Feb 2026 - Dr. Beth C. Seidenberg ("Seidenberg") has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,657,257 shares of Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX).
This represents 7.8% ownership of the company.
This is the first filing by Westlake BioPartners Fund I, L.P. disclosing ownership of Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX).